Details for New Drug Application (NDA): 086240
✉ Email this page to a colleague
The generic ingredient in KENALOG-H is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 086240
Tradename: | KENALOG-H |
Applicant: | Delcor Asset Corp |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086240
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 086240
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Delcor Asset Corp | KENALOG-H | triamcinolone acetonide | CREAM;TOPICAL | 086240-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription